UPEXI, INC. (UPXI)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

6 annual periodsNewest to oldest
202520242023202220212020
Revenue$15.8M$26.0M$36.4M$23.1M$24.1M$7.4M
Gross profit$10.9M$12.8M$21.0M$14.9M$11.9M$2.6M
Operating expenses$23.4M$35.3M$33.3M$21.4M$10.5M$7.4M
Operating income−$12.5M−$22.5M−$12.3M−$6.5M$1.4M−$4.8M
EBITDAderived−$11.7M−$18.8M−$8.8M−$3.8M$2.5M−$4.2M
Net income−$13.7M−$23.7M−$17.5M−$2.0M$3.0M−$5.4M
Basic EPSper diluted share-$1.73-$23.03-$18.94-$0.43$0.25-$0.53
Diluted EPSper diluted share-$1.73-$23.03-$18.94-$0.43$0.21-$0.53

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys16$4.55M disclosed value
Sells (SEC code S)0$0.00 disclosed value
16 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Dec 23, 2025Form 4MARSHALL ALLANChief Executive OfficerBuyCommon Stock50.0K$1.80$90.0K4.05M
Dec 16, 2025Form 4MARSHALL ALLANChief Executive OfficerBuyCommon Stock50.0K$2.07$103.5K4.00M
Dec 15, 2025Form 4MARSHALL ALLANChief Executive OfficerBuyCommon Stock100.0K$2.07$207.0K3.95M
Nov 20, 2025Form 4Salkind GeneDirectorBuyCommon Stock · indirect50.0K$2.55$127.5K218.8K
Nov 17, 2025Form 4Salkind GeneDirectorBuyCommon Stock · indirect100.0K$2.81$281.0K168.8K